{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:35Z","timestamp":1793042795049,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ygyno.2013.12.034","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T17:47:33Z","timestamp":1388684853000},"page":"377-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia"],"prefix":"10.1016","volume":"132","clinical-trial-number":[{"clinical-trial-number":"nct00303823","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Francisco A.R.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Cornelison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Nu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Byron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Hsieh","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-H. Sherry","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.12.034_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Human papillomavirus and cervical cancer-burden and assessment causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1016\/j.ygyno.2013.12.034_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2013.12.034_bb0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/IGC.0b013e3181c7ca5c","article-title":"Green tea compound in chemoprevention of cervical cancer","volume":"20","author":"Zou","year":"2010","journal-title":"Intl J Gyn Cancer"},{"issue":"13","key":"10.1016\/j.ygyno.2013.12.034_bb0020","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1074\/jbc.M312333200","article-title":"Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1\/2 and AKT kinases","volume":"279","author":"Sah","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.034_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ygyno.2003.09.023","article-title":"The tea polyphenol, (\u2212)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines","volume":"92","author":"Yokoyama","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.12.034_bb0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1535-7163.MCT-05-0490","article-title":"Green tea extract and (\u2212)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells","volume":"5","author":"Zhang","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.ygyno.2013.12.034_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008469-200310000-00007","article-title":"Protective effects of green tea extracts (Polyphenon E and EGCG) on human cervical lesions","volume":"12","author":"Ahn","year":"2003","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"10.1016\/j.ygyno.2013.12.034_bb0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0b013e3181719b60","article-title":"Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial","volume":"111","author":"Tatti","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.12.034_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-3758(00)00228-7","article-title":"Randomization, balance, and the validity and efficiency of design-adaptive allocation methods","volume":"94","author":"Aickin","year":"2001","journal-title":"J Stat Plan Infer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.034_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/gyno.2001.6245","article-title":"The correlation between colposcopically directed cervical biopsy and loop electrosurgical excision procedure pathology and the effect of time on that agreement","volume":"82","author":"Barker","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.034_bb0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jnci\/86.7.539","article-title":"Enhancement of regression of CIN II with topically applied all-trans-retinoic acid: a randomzied trial","volume":"86","author":"Meyskens","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.12.034_bb0060","doi-asserted-by":"crossref","unstructured":"Romney, S.L., et al., Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol, 65. 65: p. 483\u2013492.","DOI":"10.1006\/gyno.1997.4697"},{"key":"10.1016\/j.ygyno.2013.12.034_bb0065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/1078-0432.390.11.1","article-title":"Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3","volume":"11","author":"Vlastos","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.034_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.2000.5847","article-title":"Placebo-controlled trial of indole-3-carbinol in the treatment of CIN","volume":"78","author":"Bell","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.034_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","article-title":"ZYC101a for treatment of high grade intraepithelial neoplasia: a randomized controlled trial","volume":"103","author":"Garcia","year":"2004","journal-title":"Obstet Gynecol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T07:59:58Z","timestamp":1688889598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581301398X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S009082581301398X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.034","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}